| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.
|
Nat Genet
|
2008
|
6.10
|
|
2
|
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
|
Nat Genet
|
2009
|
6.04
|
|
3
|
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
|
Nat Genet
|
2013
|
5.58
|
|
4
|
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
|
Cancer Res
|
2003
|
3.39
|
|
5
|
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
Nat Genet
|
2011
|
3.07
|
|
6
|
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
3.05
|
|
7
|
Nonparametric tests of association of multiple genes with human disease.
|
Am J Hum Genet
|
2005
|
2.87
|
|
8
|
Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
|
Cancer Res
|
2007
|
2.56
|
|
9
|
Caution on pedigree haplotype inference with software that assumes linkage equilibrium.
|
Am J Hum Genet
|
2002
|
2.51
|
|
10
|
Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci.
|
Am J Hum Genet
|
2004
|
2.31
|
|
11
|
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
|
Hum Genet
|
2012
|
2.18
|
|
12
|
Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
2.11
|
|
13
|
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
|
Cancer Res
|
2005
|
2.02
|
|
14
|
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.
|
Am J Hum Genet
|
2005
|
1.96
|
|
15
|
Mutations in CHEK2 associated with prostate cancer risk.
|
Am J Hum Genet
|
2003
|
1.96
|
|
16
|
Risk tables for parkinsonism and Parkinson's disease.
|
J Clin Epidemiol
|
2002
|
1.86
|
|
17
|
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics.
|
Hum Genet
|
2006
|
1.70
|
|
18
|
Assessment of genotype imputation methods.
|
BMC Proc
|
2009
|
1.68
|
|
19
|
Survival study of Parkinson disease in Olmsted County, Minnesota.
|
Arch Neurol
|
2003
|
1.63
|
|
20
|
Multiple genetic variant association testing by collapsing and kernel methods with pedigree or population structured data.
|
Genet Epidemiol
|
2013
|
1.60
|
|
21
|
Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.57
|
|
22
|
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
|
Hum Mol Genet
|
2012
|
1.47
|
|
23
|
Analysis of the RNASEL gene in familial and sporadic prostate cancer.
|
Am J Hum Genet
|
2002
|
1.41
|
|
24
|
Nonfatal cancer preceding Parkinson's disease: a case-control study.
|
Epidemiology
|
2002
|
1.36
|
|
25
|
Genome-wide transcriptional profiling reveals microRNA-correlated genes and biological processes in human lymphoblastoid cell lines.
|
PLoS One
|
2009
|
1.35
|
|
26
|
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.
|
Blood
|
2012
|
1.26
|
|
27
|
Familial aggregation of Parkinson's disease: The Mayo Clinic family study.
|
Ann Neurol
|
2004
|
1.21
|
|
28
|
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics.
|
Hum Mol Genet
|
2007
|
1.20
|
|
29
|
Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project.
|
Prostate
|
2006
|
1.17
|
|
30
|
Polymorphisms in mitochondrial genes and prostate cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.17
|
|
31
|
Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness.
|
Prostate
|
2006
|
1.16
|
|
32
|
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
|
Cancer
|
2003
|
1.11
|
|
33
|
Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
|
Prostate
|
2003
|
1.11
|
|
34
|
Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb.
|
Hum Genet
|
2007
|
1.10
|
|
35
|
Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study.
|
Mov Disord
|
2005
|
1.09
|
|
36
|
The Mayo Clinic family study of Parkinson's disease: study design, instruments, and sample characteristics.
|
Neuroepidemiology
|
2005
|
1.08
|
|
37
|
Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies.
|
Genet Epidemiol
|
2011
|
1.06
|
|
38
|
Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease.
|
Arch Neurol
|
2007
|
1.05
|
|
39
|
Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease.
|
Mov Disord
|
2007
|
1.00
|
|
40
|
Barrett's esophagus: prevalence in symptomatic relatives.
|
Am J Gastroenterol
|
2002
|
0.98
|
|
41
|
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
|
Hum Genet
|
2011
|
0.97
|
|
42
|
Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
|
Hum Genet
|
2015
|
0.95
|
|
43
|
Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage.
|
Hum Mol Genet
|
2009
|
0.94
|
|
44
|
Genome-wide linkage scan of prostate cancer Gleason score and confirmation of chromosome 19q.
|
Hum Genet
|
2007
|
0.94
|
|
45
|
Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.
|
Hum Genet
|
2013
|
0.93
|
|
46
|
No association of germline alteration of MSR1 with prostate cancer risk.
|
Nat Genet
|
2003
|
0.93
|
|
47
|
Frequency of defective DNA mismatch repair in colorectal cancer among the Alaska Native people.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.89
|
|
48
|
Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.88
|
|
49
|
Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.
|
Prostate
|
2010
|
0.88
|
|
50
|
Single versus multiple imputation for genotypic data.
|
BMC Proc
|
2009
|
0.88
|
|
51
|
Identification of novel variants in colorectal cancer families by high-throughput exome sequencing.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.88
|
|
52
|
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk.
|
Cancer Res
|
2006
|
0.86
|
|
53
|
Mutational landscape of candidate genes in familial prostate cancer.
|
Prostate
|
2014
|
0.85
|
|
54
|
Estimation of genotype relative risks from pedigree data by retrospective likelihoods.
|
Genet Epidemiol
|
2010
|
0.84
|
|
55
|
Comparison of tagging single-nucleotide polymorphism methods in association analyses.
|
BMC Proc
|
2007
|
0.84
|
|
56
|
Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus.
|
Hum Mol Genet
|
2010
|
0.83
|
|
57
|
Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer.
|
Cancer Genet Cytogenet
|
2004
|
0.82
|
|
58
|
Detecting genomic clustering of risk variants from sequence data: cases versus controls.
|
Hum Genet
|
2013
|
0.81
|
|
59
|
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.
|
Prostate
|
2011
|
0.81
|
|
60
|
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes.
|
Br J Haematol
|
2012
|
0.80
|
|
61
|
Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14.
|
Eur J Hum Genet
|
2010
|
0.79
|
|
62
|
Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer.
|
Prostate
|
2003
|
0.78
|
|
63
|
Case-control study of estrogen receptor gene polymorphisms in Parkinson's disease.
|
Mov Disord
|
2002
|
0.77
|
|
64
|
Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.
|
BMC Med Genet
|
2012
|
0.76
|
|
65
|
Affected relative pairs and simultaneous search for two-locus linkage in the presence of epistasis.
|
Genet Epidemiol
|
2007
|
0.76
|
|
66
|
Linkage analysis using principal components of gene expression data.
|
BMC Proc
|
2007
|
0.75
|
|
67
|
Searching for epistasis and linkage heterogeneity by correlations of pedigree-specific linkage scores.
|
Genet Epidemiol
|
2008
|
0.75
|
|
68
|
Lack of referral bias in genetic studies of prostate cancer.
|
Epidemiology
|
2002
|
0.75
|
|
69
|
Conference Scene: Lessons learned from the 5th Statistical Analysis Workshop of the Pharmacogenetics Research Network.
|
Pharmacogenomics
|
2010
|
0.75
|